Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Interventions to manage intolerance among patients prescribed statins for primary prevention of cardiovascular diseases: A systematic review and meta-analysis
View through CrossRef
Abstract
The objective of this systematic review and meta-analysis was to identify the interventions used to manage intolerance in patients receiving statins for primary prevention of CVD and to determine the effectiveness of these interventions. This study was conducted according to the PRISMA checklist. The electronic databases MEDLINE (PubMed), SCOPUS, EMBASE, and CINAHL were searched for studies published until June 2025. Based on the NLA definition of statin intolerance, the outcomes were split into adverse effects caused by statins and statin discontinuation. In total, 1,238 studies were identified and screened. Nine studies were eligible for systematic review, and six studies were eligible for meta-analysis. The identified intervention strategies were adjuvant therapy, statin titration, replacing statins with other lipid-lowering agents and switching to different statin. The meta-analysis showed that the pooled risk ratio (RR) relative to control was 0.97 (95% CI, 0.86–1.08) in randomized controlled trials and 0.94 (95% CI, 0.63–1.42) in overall, with point estimates in favour of intervention arms. Moderate to substantial heterogeneity was observed, with I
2
between 27% to 57%. Due to the smaller number of studies, no clear conclusions can be drawn regarding how the implemented interventions may affect statin discontinuation. This study showed no strong evidence that the implemented interventions reduced statin intolerance.
PROSPERO registration number
CRD42024587573
Highlights
This study found that the intervention strategies used to manage intolerance in patients receiving statins for the primary prevention of cardiovascular diseases were adjuvant therapy, statin titration, replacing statins with other lipid-lowering agents and switching to different statin.
This study showed no strong evidence that the implemented interventions reduced statin intolerance
Due to the smaller number of studies, no clear conclusions can be drawn regarding how the implemented interventions may affect statin discontinuation
Title: Interventions to manage intolerance among patients prescribed statins for primary prevention of cardiovascular diseases: A systematic review and meta-analysis
Description:
Abstract
The objective of this systematic review and meta-analysis was to identify the interventions used to manage intolerance in patients receiving statins for primary prevention of CVD and to determine the effectiveness of these interventions.
This study was conducted according to the PRISMA checklist.
The electronic databases MEDLINE (PubMed), SCOPUS, EMBASE, and CINAHL were searched for studies published until June 2025.
Based on the NLA definition of statin intolerance, the outcomes were split into adverse effects caused by statins and statin discontinuation.
In total, 1,238 studies were identified and screened.
Nine studies were eligible for systematic review, and six studies were eligible for meta-analysis.
The identified intervention strategies were adjuvant therapy, statin titration, replacing statins with other lipid-lowering agents and switching to different statin.
The meta-analysis showed that the pooled risk ratio (RR) relative to control was 0.
97 (95% CI, 0.
86–1.
08) in randomized controlled trials and 0.
94 (95% CI, 0.
63–1.
42) in overall, with point estimates in favour of intervention arms.
Moderate to substantial heterogeneity was observed, with I
2
between 27% to 57%.
Due to the smaller number of studies, no clear conclusions can be drawn regarding how the implemented interventions may affect statin discontinuation.
This study showed no strong evidence that the implemented interventions reduced statin intolerance.
PROSPERO registration number
CRD42024587573
Highlights
This study found that the intervention strategies used to manage intolerance in patients receiving statins for the primary prevention of cardiovascular diseases were adjuvant therapy, statin titration, replacing statins with other lipid-lowering agents and switching to different statin.
This study showed no strong evidence that the implemented interventions reduced statin intolerance
Due to the smaller number of studies, no clear conclusions can be drawn regarding how the implemented interventions may affect statin discontinuation.
Related Results
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Evaluating the Science to Inform the Physical Activity Guidelines for Americans Midcourse Report
Abstract
The Physical Activity Guidelines for Americans (Guidelines) advises older adults to be as active as possible. Yet, despite the well documented benefits of physical a...
Abstract 1855: Statins decrease the expression of c myc in cancer cell lines
Abstract 1855: Statins decrease the expression of c myc in cancer cell lines
Abstract
The widely used statin drugs for the prevention of cardiovascular diseases are envisioned to have the potential to control cancer. Repurposing these cardiov...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Abstract 4144000: The association between statins and immune checkpoint inhibitor-associated cardiotoxicity
Abstract 4144000: The association between statins and immune checkpoint inhibitor-associated cardiotoxicity
Background:
Immune checkpoint inhibitors (ICIs) have been associated with major adverse cardiovascular events (MACE) that carry high morbidity and mortality. Statins ar...
Digital Mental Health Landscaping in Low- and Middle-Income Countries
Digital Mental Health Landscaping in Low- and Middle-Income Countries
Introduction
The aim of this project was to map the landscape of who is doing what and where in digital mental health, and to pr...
Electronic health record (EHR)-detectable statin intolerance phenotypes: Prevalence and validation in real-world general practice
Electronic health record (EHR)-detectable statin intolerance phenotypes: Prevalence and validation in real-world general practice
ABSTRACT
Aims
This study focused on patients who were prescribed statins as primary prevention of cardiovascular diseases. This...
Hypotensive Effects of Statins: A Rapid Review
Hypotensive Effects of Statins: A Rapid Review
Introduction: Recently, hypertension has become a major global health concern that plays a substantial role in morbidity and mortality related to Cardiovascular Disease (CVD). Alth...
Statins Formulary Selection in Qatar, Based on Multi-Indication Pharmacotherapeutic Multi-Criteria Scoring, and Clinician Preference
Statins Formulary Selection in Qatar, Based on Multi-Indication Pharmacotherapeutic Multi-Criteria Scoring, and Clinician Preference
PurposeStatins selection for the largest hospital formulary in Qatar is not systematic, not comparative, not cost saving, and does not consider the multi-indication nature of stati...